Skip to main content

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Archive
    • Subject Collections
    • Special Collections
  • Reviews & Opinions
    • Editorials
    • People & Ideas
    • Spotlights
    • Viewpoints
    • Inside Look
    • Reviews
    • biosights podcast
  • Alerts
  • About
    • History
    • Editors & Staff
    • Permissions & Licensing
    • Advertise
    • Contact Us
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Publication Fees
    • Author Services
  • Subscriptions
  • Rockefeller University Press
  • JCB
  • JEM
  • JGP
  • LSA

User menu

  • Log in

Search

  • Advanced search
JCB
  • Rockefeller University Press
  • JCB
  • JEM
  • JGP
  • LSA
  • Log in
JCB

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Archive
    • Subject Collections
    • Special Collections
  • Reviews & Opinions
    • Editorials
    • People & Ideas
    • Spotlights
    • Viewpoints
    • Inside Look
    • Reviews
    • biosights podcast
  • Alerts
  • About
    • History
    • Editors & Staff
    • Permissions & Licensing
    • Advertise
    • Contact Us
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Publication Fees
    • Author Services
  • Subscriptions

You are here

jcb Home » 2015 Archive » 13 April » 209 (1): 85
Article

Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway

Fubito Nakatsu, Mirko Messa, Ramiro Nández, Heather Czapla, Yixiao Zou, Stephen M. Strittmatter, Pietro De Camilli
Fubito Nakatsu
Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mirko Messa
Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramiro Nández
Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Czapla
Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yixiao Zou
Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Strittmatter
Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pietro De Camilli
Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510Department of Cell Biology, Howard Hughes Medical Institute, Department of Neurology, and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1083/jcb.201409064 | Published April 13, 2015
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Preview PDF
Loading

Data supplements

  • Files in this Data Supplement:

    • Supplemental Material (PDF)
    • Video 1 -
      GFP-Sac2 dynamics at the late-stage clathrin-coated pits. COS7 cells were transfected with GFP-Sac2 and CLC-mRFP. Live imaging by spinning-disk confocal microscopy (UltraView VoX system; PerkinElmer) demonstrates endocytic clathrin-coated pit dynamics showing recruitment of GFP-Sac2 (green) at clathrin-coated pits just when the clathrin signal (CLC-mRFP, red) is about to disappear. Bar, 2 µm.

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Localization of Sac2 on endosomes. (A and B) GFP- or mCherry (mCh)-Sac2 is present on Rab5-positive endosomes, as shown by colocalization with endogenous Rab5 immunoreactivity (A) or with GFP-Rab5 (B). (C and D) GFP-Sac2 also colocalizes with the majority of APPL1 (RFP-APPL1)-positive endosomes (C), but does not colocalize with a lysosomal marker protein, RFP-LAMP1 (D). In A, B, and C, examples of colocalizations are indicated by arrows. Images were taken by spinning-disc confocal microscopy. Bars, 5 µm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Colocalization of Sac2 with OCRL on early endosomes and at the last stage of clathrin-mediated endocytosis. Live spinning-disc confocal microscopy. (A) Colocalization of GFP-Sac2 and mCherry-OCRL. The majority of the fluorescent puncta positive for both proteins are expected to be early endosomes, given the close colocalization of both proteins with Rab5 (see Fig. 1 A and Hyvola et al., 2006; Erdmann et al., 2007). Insets show enlarged views of the regions boxed in yellow. (B and C) Time course of CLC-mRFP and either GFP-Sac2 (B) or GFP-OCRL (C) fluorescence intensities at very late stage clathrin-coated pits demonstrating that Sac2 and OCRL appear when clathrin is disappearing, and that Sac2 and OCRL display similar recruitment patterns. The disappearance of the Sac2 and OCRL fluorescence reflects the newly formed vesicle moving out of the focal plane. Bars: (A) 5 µm; (B and C) 1 µm.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Recruitment of Sac2 to macropinosomes. Mouse fibroblasts expressing GFP-Sac2 and either RFP-PHAKT (A) or RFP-EEA1 (B) were also cotransfected with H-RasV12G to induce the formation of macropinosomes. The gallery of confocal images shows that Sac2 is recruited to these vesicles when the AKT signal, which primarily reflects PI(3,4,5)P3, is disappearing, and remains associated with the vesicles as they mature to EEA1-positive endosomes. Bars, 1 µm.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Defect in the internalization of transferrin in Sac2 KO MEFs. Internalization of biotinylated transferrin over time was analyzed biochemically in WT and Sac2 KO MEFs using an ELISA-based assay (see Materials and methods for details). Data were expressed as mean ± SD (error bars) of three independent experiments (Student’s t test, **, P < 0.01; ***, P < 0.001).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Sac2 functions downstream of Rab5 and is part of a complex also comprising OCRL. (A–C) COS7 cells were cotransfected with mCherry (mCh)-Sac2 together with GFP-Rab5WT, GFP-Rab5Q79L (constitutively active; B), or GFP-Rab5S34N (dominant negative; C), as indicated, and imaged by confocal microscopy. mCh-Sac2 colocalizes with WT and constitutively active Rab5. In contrast, it has a predominant cytosolic localization in cells expressing dominant-negative Rab5. Inset panels show enlarged views of the regions boxed in yellow. Bars: (full-size images) 5 µm; (insets) 2 µm for inset image. (D) COS7 cells were cotransfected with 3×Flag-Sac2, HA-OCRL, and GFP-tagged Rab5 constructs (Rab5WT, GFP-Rab5Q79L, or GFP-Rab5S34N). Cell lysates were immunoprecipitated with anti-Flag antibody to enrich for Sac2. Immunoblotting of the starting lysates (left) and of the immunoprecipitates (right) for the Flag, HA, and GFP epitopes confirms enrichment of Sac2 and shows robust coprecipitation of Rab5 and OCRL only from cells expressing GFP-Rab5WT or GFP-Rab5Q79L. Recovery of OCRL and Rab5 was dramatically reduced from cells expressing Rab5S34N.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Sac2 is an inositol 4-phosphatase. (A) GFP, GFP-Sac2, and GFP-Sac2D460N were transiently overexpressed in Expi293 HEK cells and semi-purified by immunoprecipitation using anti-GFP antibody. The presence of inositol-phosphatase activity in the immunoprecipitated material was assessed with a malachite-based assay. Data shown represent mean ± SD (error bars). (B) Lysates of COS-7 cells expressing GFP, GFP-Sac2WT, or GFP-Sac2D460N were subjected to anti-GFP immunoprecipitation, and immunoprecipitates were processed by immunoblotting to assess the enrichment of GFP and GFP fusion proteins (bottom), of inositol phosphatases (OCRL, INPP5B, and synaptojanin 1), and of control proteins (epsin 1 and Erk1/2). Note the enrichment of OCRL and INPP5B in anti-GFP immunoprecipates from COS7 cells expressing GFP-Sac2WT or GFP-Sac2D460N. (C) GST-SacWT and GST-SacD460N were expressed in bacteria, purified on glutathione Sepharose beads, and analyzed for inositol phosphatase activity against the seven PIs via the malachite assay. Data shown represent mean ± SD (error bars).

Previous articleNext article
Back to top
Download PDF
PDF + Supp Data
Citation Tools
Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway
Fubito Nakatsu, Mirko Messa, Ramiro Nández, Heather Czapla, Yixiao Zou, Stephen M. Strittmatter, Pietro De Camilli
J Cell Biol Apr 2015, 209 (1) 85-95; DOI: 10.1083/jcb.201409064

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts
Sign In to Email Alerts with your Email Address

Email logo Twitter logo Facebook logo Mendeley logo Reddit logo CiteULike logo LinkedIn logo

The Journal of Cell Biology: 218 (2)

Current Issue

February 4, 2019
Volume 218, No. 2

  • Table of Contents
  • All Issues

Jump To

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info
  • Metrics
  • Preview PDF
 

ARTICLES

  • Current Issue
  • Newest Articles
  • Archive
  • Alerts
  • RSS feeds

FOR AUTHORS

  • Submit a Manuscript
  • Instructions for Authors

ABOUT

  • About JCB
  • Editors & Staff
  • Permissions & Licensing
  • Advertise
  • Contact Us
  • Feedback
  • Newsroom
  • Privacy Policy

CONNECT WITH JCB

  • Email
  • Facebook
  • Twitter
  • RSS
  • Instagram

Online ISSN: 1540-8140
Print ISSN: 0021-9525

Copyright © 2019 JCB by Rockefeller University Press